Frontiers in bioscience (Landmark edition)HumansReceptorFibroblast Growth FactorType 4Neoplasms
One Size Does Not Fit All: Precision Combinations for FGFR4-driven Cancers.
Emmy D G Fleuren
Published: 202510.31083/FBL43996
Abstract
Oncogenic FGFR4 signalling represents an attractive therapeutic target across multiple cancers, yet treatment resistance almost uniformly occurs. A critical mechanism steering resistance is a rapid and complex reprogramming of kinase signalling netwo…
Preview only. Read the full abstract at the source